New York, NYCIK 16433544 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
39 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Milestone Pharmaceuticals In | 755.0K | $1.53M | 7.9% | +96.4K | Added |
| 2 | Praxis Precision Medicines I | 4.5K | $1.31M | 6.8% | −1.3K | Reduced |
| 3 | Moonlake Immunotherapeutics | 67.5K | $889.6K | 4.6% | 0 | Held |
| 4 |
| 112.4K |
| $865.7K |
| 4.5% |
| −10.6K |
| Reduced |
| 5 | Jasper Therapeutics Inc | 465.0K | $851.0K | 4.4% | +66.4K | Added |
| 6 | Benitec Biopharma Inc | 62.0K | $835.1K | 4.3% | 0 | Held |
| 7 | Royalty Pharma PLC | 21.4K | $826.9K | 4.3% | 0 | Held |
| 8 | Geron Corp | 578.0K | $763.0K | 3.9% | +78.0K | Added |
| 9 | Syndax Pharmaceuticals Inc | 36.0K | $756.4K | 3.9% | −19.0K | Reduced |
| 10 | Ardelyx Inc | 128.7K | $750.0K | 3.9% | −34.1K | Reduced |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio